Glioblastoma Multiforme (GBM) Treatment Market Summary The global glioblastoma multiforme (GBM) treatment market was valued at USD 3.72 billion in 2024 and is expected to reach USD 7.87 billion by 2033, expanding at a CAGR of 8.68% from 2025 to 2033. Market growth is primarily driven by the rising prevalence of GBM and the substantial clinical burden associated with this aggressive...